OIP5 and lung carcinoma: Opa interacting protein 5 (OIP5) was a member of cancer-testis antigen (CTA) family, which might be a novel therapeutic target for cancer therapy because of the high expression of this gene in colorectal cancer 49, lung cancer 50, and esophageal cancer 50.